Warning: fopen(/home/virtual/epih/journal/upload/ip_log/ip_log_2024-12.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96
1Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea
2Center for Colorectal Cancer, National Cancer Center, Goyang, Korea
3Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea
4Cancer Research Institute, Seoul National University, Seoul, Korea
© 2022, Korean Society of Epidemiology
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
The authors have no conflicts of interest to declare for this study.
FUNDING
This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2021R1A6A3A01087058), by an NRF grant funded by the Ministry of Science and IST (2021 R1A2C2008439), and by a research grant from the National Cancer Center in Korea (2010260).
AUTHOR CONTRIBUTIONS
Conceptualization: Jun S. Data curation: Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J. Funding acquisition: Jun S, Kim J. Methodology: Jun S. Project administration: Lee J. Visualization: Jun S. Writing – original draft: Jun S. Writing – review & editing: Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J.
Components | Descriptions | Weights2 |
---|---|---|
DIS components3 | ||
Leafy greens and cruciferous vegetables | Spinach, cabbage or coleslaw, lettuce, watercress, kale, broccoli, bok choy, radish, other leafy greens, Kimchi or pickled radish | −0.19 |
Tomatoes | Tomatoes, tomato juice, tomato puree, and ketchup | −0.88 |
Deep yellow and orange vegetables and fruits | Peaches, persimmons, carrots, pumpkins | −0.11 |
Apples, berries, other fruits, and real fruit juices | Apples, pears, strawberries, watermelon, grapes, bananas, oranges, muskmelon, Korean melon, real fruit juice | −0.33 |
Other vegetables | Garlic, peppers, ginger, zucchini, celery, mushrooms, onion, green onion, soybean or mung bean sprouts, root vegetables, pickled vegetables | 0.62 |
Legumes | Peas, soybeans, soy products | 0.20 |
Fish and shellfish | White meat or dark meat fish, breaded fish cakes or fish sticks, shellfish | −0.36 |
Poultry | Chicken with and without skin | 0.43 |
Red and organ meats | Beef, pork, organ meats | 0.36 |
Processed meats | Ham, bacon, sausage | 0.30 |
Added sugars | Sugar-sweetened soda, lemonade, jams, preserves, dried or canned fruit, syrup, honey, candy bars, chocolate, candy | 0.24 |
Dairy | Milk, yogurt, cheese, ice cream | 0.42 |
Coffee and tea | Coffee, green tea, herbal tea | 0.16 |
Nuts and seeds | Peanuts, almonds, pine nuts, sesame seeds | −0.31 |
Other fats | Vegetable oil, mayonnaise, butter, margarine | 0.04 |
Refined grains and starchy vegetables | White rice, noodles, ready-to-eat breakfast cereals, bread, cake, cookies, chips, crackers, biscuits, rice cakes, potato, sweet potato, starch | 0.21 |
Whole grains | Brown rice, barley, sorghum, millet | −0.45 |
Seaweed | Gim (nori), miyeok (wakame), dashima (konbu) | −0.55 |
Supplement use | Consumers of multi- or single-vitamin and minerals vs. non-consumers | −0.67 |
|
||
LIS components4 | ||
Heavy drinker | >14 drinks/wk for male and >7 drinks/wk for female | 0.58 |
Moderate drinker | >0 to ≤14 drinks/wk for male and >0 to ≤7 drinks/wk for female | −0.65 |
Heavily physically active | The highest tertile of MET-min/wk (using cut-offs based on the distribution among controls) | −0.66 |
Moderately physically active | The middle tertile of MET-min/wk (using cut-offs based on the distribution among controls) | −0.29 |
Current smoker | Currently smoking tobacco | 4.22 |
Obese BMI | BMI ≥25 kg/m2 | 4.08 |
DIS, dietary inflammation score; LIS, lifestyle inflammation score; MET, metabolic equivalent of task; BMI, body mass index.
1 Modified from Byrd et al. [8] to reflect the dietary intake and body weight status of Korean adults.
2 β-coefficient weights were obtained from a multivariable linear regression model according to the method used by Byrd et al. [8] in 1,842 controls with reliable data on high-sensitivity C-reactive protein (hs-CRP); The multivariable linear regression models represented the average change in a log-transformed hs-CRP concentration per 1 standard deviation increase in a DIS component or the presence of a LIS component; Covariates in the model included age, sex, case/control status, comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other non-steroidal anti-inflammatory drugs (≥ once/wk), hormone replacement therapy (among females), log-transformed total energy intake, and all the DIS and LIS components.
3 Each DIS component was log-transformed and standardized by sex based on the distribution among controls.
4 All LIS components were dummy-coded as “1” for the non-reference category and “0” for the reference category.
Characteristics | Cases (n=919) | Controls (n=1,846)1 | p-value2 |
---|---|---|---|
Demographics | |||
Age (yr) | 56.6±9.7 | 56.1±9.1 | 0.243 |
Female | 297 (32.3) | 596 (32.3) | 0.987 |
College graduate or more | 232 (25.2) | 941 (51.0) | <0.001 |
|
|||
Medical history | |||
Aspirin or NSAID use (≥once/wk) | 22 (2.4) | 205 (11.1) | <0.001 |
Comorbidity3 | 123 (13.4) | 201 (10.9) | 0.055 |
Hormone therapy4 | 8 (2.7) | 32 (5.4) | 0.069 |
First-degree relative history of CRC | 86 (9.4) | 99 (5.4) | <0.001 |
|
|||
Lifestyle | |||
Obese (BMI >25 kg/m2) | 324 (35.3) | 681 (36.9) | 0.400 |
Current smoker | 195 (21.2) | 341 (18.5) | 0.085 |
Alcohol consumption | <0.001 | ||
Non-drinker | 343 (37.3) | 650 (35.2) | |
Moderate drinker | 360 (39.2) | 961 (52.1) | |
Heavy drinker | 216 (23.5) | 235 (12.7) | |
Physical activity (MET-hr/wk)5 | 44.6±49.2 | 56.1±83.3 | 0.271 |
LIS | 1.9±2.7 | 1.7±2.7 | <0.001 |
|
|||
Dietary intake | |||
Total energy (kcal/day) | 2,027.9±533.4 | 1,689.6±560.4 | <0.001 |
DIS | 0.6±1.7 | −0.2±1.7 | <0.001 |
Values are presented as mean±standard deviation or number (%); Percentages may not add up to 100% due to rounding.
NSAID, non-steroidal anti-inflammatory drug; BMI, body mass index; DIS, dietary inflammation score; LIS, lifestyle inflammation score; MET, metabolic equivalent of task.
1 Missing 43 controls for the education variable.
2 Differences between cases and controls were tested using the chi-square test for categorical variables and the Wilcoxon rank sum test for continuous variables with a non-normal distribution.
3 Any history of heart disease, diabetes mellitus, or cancer other than colorectal cancer.
4 Among females only (297 cases and 596 controls).
5 According to tertile cut-offs from the distribution of controls’ MET.
Inflammation scores | Colorectal cancer | Proximal colon cancer | Distal colon cancer | Rectal cancer | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
Case/control, n | OR (95% CI) | Case/control, n | OR (95% CI) | Case/control, n | OR (95% CI) | Case/control, n | OR (95% CI) | |
Model 1 | ||||||||
DIS2 | ||||||||
T1 | 159/615 | 1.00 (reference) | 34/615 | 1.00 (reference) | 53/615 | 1.00 (reference) | 71/615 | 1.00 (reference) |
T2 | 273/616 | 1.52 (1.19, 1.94 ) | 44/616 | 1.23 (0.77, 1.99) | 91/616 | 1.53 (1.06, 2.23) | 131/616 | 1.66 (1.20, 2.31) |
T3 | 487/615 | 2.72 (2.15, 3.43) | 87/615 | 2.38 (1.54, 3.69) | 150/615 | 2.56 (1.79, 3.66) | 241/615 | 3.02 (2.22, 4.12) |
p-for-trend | <0.001 | <0.001 | <0.001 | <0.001 | ||||
LIS3 | ||||||||
T1 | 273/636 | 1.00 (reference) | 46/636 | 1.00 (reference | 94/636 | 1.00 (reference) | 129/636 | 1.00 (reference) |
T2 | 280/647 | 1.02 (0.83, 1.25) | 56/647 | 1.19 (0.79, 1.80) | 76/647 | 0.78 (0.56, 1.09) | 140/647 | 1.08 (0.83, 1.42) |
T3 | 366/563 | 1.44 (1.17, 1.76) | 63/563 | 1.51 (1.00, 2.26) | 124/563 | 1.42 (1.05, 1.92) | 174/563 | 1.46 (1.12, 1.90) |
p-for-trend | <0.001 | 0.048 | 0.018 | 0.005 | ||||
|
||||||||
Model 2 | ||||||||
DIS4 | ||||||||
T1 | 159/615 | 1.00 (reference) | 34/615 | 1.00 (reference) | 53/615 | 1.00 (reference) | 71/615 | 1.00 (reference) |
T2 | 273/616 | 1.48 (1.16, 1.90) | 44/616 | 1.19 (0.73, 1.92) | 91/616 | 1.50 (1.03, 2.19) | 131/616 | 1.63 (1.17, 2.27) |
T3 | 487/615 | 2.65 (2.10, 3.36) | 87/615 | 2.35 (1.51, 3.67) | 150/615 | 2.53 (1.77, 3.63) | 241/615 | 3.00 (2.19, 4.10) |
p-for-trend | <0.001 | <0.001 | <0.001 | <0.001 | ||||
LIS5 | ||||||||
T1 | 273/636 | 1.00 (reference) | 46/636 | 1.00 (reference) | 94/636 | 1.00 (reference) | 129/636 | 1.00 (reference) |
T2 | 280/647 | 0.98 (0.79, 1.23) | 56/647 | 1.12 (0.73, 1.70) | 76/647 | 0.74 (0.53, 1.04) | 140/647 | 1.00 (0.75, 1.33) |
T3 | 366/563 | 1.28 (1.03, 1.59) | 63/563 | 1.33 (0.88, 2.03) | 124/563 | 1.22 (0.89, 1.67) | 174/563 | 1.23 (0.93, 1.63) |
p-for-trend | 0.023 | 0.173 | 0.185 | 0.134 |
DIS, dietary inflammation score; LIS, lifestyle inflammation score; OR, odds ratio; CI, confidence interval; NSAID, non-steroidal anti-inflammatory drug.
1 The tertile cut-offs for DIS were ≤−0.91 (T1) and >0.56 (T3) among males and ≤−0.92 (T1) and >0.47 (T3) among females; The tertile cut-offs for LIS were ≤−0.29 (T1) and >3.43 (T3) among males and ≤−0.65 (T1) and >0 (T3) among females.
2 Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), first-degree relative history of colorectal cancer (yes/no), and total energy intake.
3 Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), and first-degree relative history of colorectal cancer (yes/no).
4 Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), first-degree relative history of colorectal cancer (yes/no), total energy intake, smoking status (current/non-current), alcohol consumption (heavy/moderate/non-drinker), obesity (yes/no), and physical activity level (heavy/moderate/not active).
5 Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart disease, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), first-degree relative history of colorectal cancer (yes/no), total energy intake, and equal-weighted DIS.
DIS, dietary inflammation score; LIS, lifestyle inflammation score; OR, odds ratio; CI, confidence interval; NSAID, non-steroidal anti-inflammatory drug.
1 The tertile cut-offs for DIS were ≤−0.91 (T1) and >0.56 (T3) among males and ≤−0.92 (T1) and >0.47 (T3) among females; The tertile cut-offs for LIS were ≤−0.29 (T1) and >3.43 (T3) among males and ≤−0.65 (T1) and >0 (T3) among females; Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), first-degree relative history of colorectal cancer (yes/no), and total energy intake; p-for-interaction was 0.026.
Components | Descriptions | Weights |
---|---|---|
DIS components | ||
Leafy greens and cruciferous vegetables | Spinach, cabbage or coleslaw, lettuce, watercress, kale, broccoli, bok choy, radish, other leafy greens, Kimchi or pickled radish | −0.19 |
Tomatoes | Tomatoes, tomato juice, tomato puree, and ketchup | −0.88 |
Deep yellow and orange vegetables and fruits | Peaches, persimmons, carrots, pumpkins | −0.11 |
Apples, berries, other fruits, and real fruit juices | Apples, pears, strawberries, watermelon, grapes, bananas, oranges, muskmelon, Korean melon, real fruit juice | −0.33 |
Other vegetables | Garlic, peppers, ginger, zucchini, celery, mushrooms, onion, green onion, soybean or mung bean sprouts, root vegetables, pickled vegetables | 0.62 |
Legumes | Peas, soybeans, soy products | 0.20 |
Fish and shellfish | White meat or dark meat fish, breaded fish cakes or fish sticks, shellfish | −0.36 |
Poultry | Chicken with and without skin | 0.43 |
Red and organ meats | Beef, pork, organ meats | 0.36 |
Processed meats | Ham, bacon, sausage | 0.30 |
Added sugars | Sugar-sweetened soda, lemonade, jams, preserves, dried or canned fruit, syrup, honey, candy bars, chocolate, candy | 0.24 |
Dairy | Milk, yogurt, cheese, ice cream | 0.42 |
Coffee and tea | Coffee, green tea, herbal tea | 0.16 |
Nuts and seeds | Peanuts, almonds, pine nuts, sesame seeds | −0.31 |
Other fats | Vegetable oil, mayonnaise, butter, margarine | 0.04 |
Refined grains and starchy vegetables | White rice, noodles, ready-to-eat breakfast cereals, bread, cake, cookies, chips, crackers, biscuits, rice cakes, potato, sweet potato, starch | 0.21 |
Whole grains | Brown rice, barley, sorghum, millet | −0.45 |
Seaweed | Gim (nori), miyeok (wakame), dashima (konbu) | −0.55 |
Supplement use | Consumers of multi- or single-vitamin and minerals vs. non-consumers | −0.67 |
| ||
LIS components | ||
Heavy drinker | >14 drinks/wk for male and >7 drinks/wk for female | 0.58 |
Moderate drinker | >0 to ≤14 drinks/wk for male and >0 to ≤7 drinks/wk for female | −0.65 |
Heavily physically active | The highest tertile of MET-min/wk (using cut-offs based on the distribution among controls) | −0.66 |
Moderately physically active | The middle tertile of MET-min/wk (using cut-offs based on the distribution among controls) | −0.29 |
Current smoker | Currently smoking tobacco | 4.22 |
Obese BMI | BMI ≥25 kg/m2 | 4.08 |
Characteristics | Cases (n=919) | Controls (n=1,846) |
p-value |
---|---|---|---|
Demographics | |||
Age (yr) | 56.6±9.7 | 56.1±9.1 | 0.243 |
Female | 297 (32.3) | 596 (32.3) | 0.987 |
College graduate or more | 232 (25.2) | 941 (51.0) | <0.001 |
| |||
Medical history | |||
Aspirin or NSAID use (≥once/wk) | 22 (2.4) | 205 (11.1) | <0.001 |
Comorbidity |
123 (13.4) | 201 (10.9) | 0.055 |
Hormone therapy |
8 (2.7) | 32 (5.4) | 0.069 |
First-degree relative history of CRC | 86 (9.4) | 99 (5.4) | <0.001 |
| |||
Lifestyle | |||
Obese (BMI >25 kg/m2) | 324 (35.3) | 681 (36.9) | 0.400 |
Current smoker | 195 (21.2) | 341 (18.5) | 0.085 |
Alcohol consumption | <0.001 | ||
Non-drinker | 343 (37.3) | 650 (35.2) | |
Moderate drinker | 360 (39.2) | 961 (52.1) | |
Heavy drinker | 216 (23.5) | 235 (12.7) | |
Physical activity (MET-hr/wk) |
44.6±49.2 | 56.1±83.3 | 0.271 |
LIS | 1.9±2.7 | 1.7±2.7 | <0.001 |
| |||
Dietary intake | |||
Total energy (kcal/day) | 2,027.9±533.4 | 1,689.6±560.4 | <0.001 |
DIS | 0.6±1.7 | −0.2±1.7 | <0.001 |
Inflammation scores | Colorectal cancer | Proximal colon cancer | Distal colon cancer | Rectal cancer | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
| |||||
Case/control, n | OR (95% CI) | Case/control, n | OR (95% CI) | Case/control, n | OR (95% CI) | Case/control, n | OR (95% CI) | |
Model 1 | ||||||||
DIS | ||||||||
T1 | 159/615 | 1.00 (reference) | 34/615 | 1.00 (reference) | 53/615 | 1.00 (reference) | 71/615 | 1.00 (reference) |
T2 | 273/616 | 1.52 (1.19, 1.94 ) | 44/616 | 1.23 (0.77, 1.99) | 91/616 | 1.53 (1.06, 2.23) | 131/616 | 1.66 (1.20, 2.31) |
T3 | 487/615 | 2.72 (2.15, 3.43) | 87/615 | 2.38 (1.54, 3.69) | 150/615 | 2.56 (1.79, 3.66) | 241/615 | 3.02 (2.22, 4.12) |
p-for-trend | <0.001 | <0.001 | <0.001 | <0.001 | ||||
LIS | ||||||||
T1 | 273/636 | 1.00 (reference) | 46/636 | 1.00 (reference | 94/636 | 1.00 (reference) | 129/636 | 1.00 (reference) |
T2 | 280/647 | 1.02 (0.83, 1.25) | 56/647 | 1.19 (0.79, 1.80) | 76/647 | 0.78 (0.56, 1.09) | 140/647 | 1.08 (0.83, 1.42) |
T3 | 366/563 | 1.44 (1.17, 1.76) | 63/563 | 1.51 (1.00, 2.26) | 124/563 | 1.42 (1.05, 1.92) | 174/563 | 1.46 (1.12, 1.90) |
p-for-trend | <0.001 | 0.048 | 0.018 | 0.005 | ||||
| ||||||||
Model 2 | ||||||||
DIS |
||||||||
T1 | 159/615 | 1.00 (reference) | 34/615 | 1.00 (reference) | 53/615 | 1.00 (reference) | 71/615 | 1.00 (reference) |
T2 | 273/616 | 1.48 (1.16, 1.90) | 44/616 | 1.19 (0.73, 1.92) | 91/616 | 1.50 (1.03, 2.19) | 131/616 | 1.63 (1.17, 2.27) |
T3 | 487/615 | 2.65 (2.10, 3.36) | 87/615 | 2.35 (1.51, 3.67) | 150/615 | 2.53 (1.77, 3.63) | 241/615 | 3.00 (2.19, 4.10) |
p-for-trend | <0.001 | <0.001 | <0.001 | <0.001 | ||||
LIS | ||||||||
T1 | 273/636 | 1.00 (reference) | 46/636 | 1.00 (reference) | 94/636 | 1.00 (reference) | 129/636 | 1.00 (reference) |
T2 | 280/647 | 0.98 (0.79, 1.23) | 56/647 | 1.12 (0.73, 1.70) | 76/647 | 0.74 (0.53, 1.04) | 140/647 | 1.00 (0.75, 1.33) |
T3 | 366/563 | 1.28 (1.03, 1.59) | 63/563 | 1.33 (0.88, 2.03) | 124/563 | 1.22 (0.89, 1.67) | 174/563 | 1.23 (0.93, 1.63) |
p-for-trend | 0.023 | 0.173 | 0.185 | 0.134 |
Variables | LIS | |||||
---|---|---|---|---|---|---|
| ||||||
T1 | T2 | T3 | ||||
|
|
| ||||
Case/control, n | OR (95% CI) | Case/control, n | OR (95% CI) | Case/control, n | OR (95% CI) | |
DIS | ||||||
T1 | 42/221 | 1.00 (reference) | 57/239 | 1.15 (0.72, 1.84) | 60/155 | 1.74 (1.08, 2.80) |
T2 | 82/232 | 1.55 (0.99, 2.42) | 87/207 | 1.86 (1.19, 2.90) | 104/177 | 2.45 (1.57, 3.83) |
T3 | 149/183 | 3.73 (2.43, 5.71) | 136/201 | 2.97 (1.93, 4.55) | 202/231 | 3.60 (2.38, 5.43) |
DIS, dietary inflammation score; LIS, lifestyle inflammation score; MET, metabolic equivalent of task; BMI, body mass index. Modified from Byrd et al. [ β-coefficient weights were obtained from a multivariable linear regression model according to the method used by Byrd et al. [ Each DIS component was log-transformed and standardized by sex based on the distribution among controls. All LIS components were dummy-coded as “1” for the non-reference category and “0” for the reference category.
Values are presented as mean±standard deviation or number (%); Percentages may not add up to 100% due to rounding. NSAID, non-steroidal anti-inflammatory drug; BMI, body mass index; DIS, dietary inflammation score; LIS, lifestyle inflammation score; MET, metabolic equivalent of task. Missing 43 controls for the education variable. Differences between cases and controls were tested using the chi-square test for categorical variables and the Wilcoxon rank sum test for continuous variables with a non-normal distribution. Any history of heart disease, diabetes mellitus, or cancer other than colorectal cancer. Among females only (297 cases and 596 controls). According to tertile cut-offs from the distribution of controls’ MET.
DIS, dietary inflammation score; LIS, lifestyle inflammation score; OR, odds ratio; CI, confidence interval; NSAID, non-steroidal anti-inflammatory drug. The tertile cut-offs for DIS were ≤−0.91 (T1) and >0.56 (T3) among males and ≤−0.92 (T1) and >0.47 (T3) among females; The tertile cut-offs for LIS were ≤−0.29 (T1) and >3.43 (T3) among males and ≤−0.65 (T1) and >0 (T3) among females. Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), first-degree relative history of colorectal cancer (yes/no), and total energy intake. Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), and first-degree relative history of colorectal cancer (yes/no). Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), first-degree relative history of colorectal cancer (yes/no), total energy intake, smoking status (current/non-current), alcohol consumption (heavy/moderate/non-drinker), obesity (yes/no), and physical activity level (heavy/moderate/not active). Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart disease, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), first-degree relative history of colorectal cancer (yes/no), total energy intake, and equal-weighted DIS.
DIS, dietary inflammation score; LIS, lifestyle inflammation score; OR, odds ratio; CI, confidence interval; NSAID, non-steroidal anti-inflammatory drug. The tertile cut-offs for DIS were ≤−0.91 (T1) and >0.56 (T3) among males and ≤−0.92 (T1) and >0.47 (T3) among females; The tertile cut-offs for LIS were ≤−0.29 (T1) and >3.43 (T3) among males and ≤−0.65 (T1) and >0 (T3) among females; Covariates in the multivariable logistic regression model included age, sex, education (college graduate or more/high school graduate or less), comorbidity (any history of cancer, heart diseases, or diabetes), regular use of aspirin or other NSAIDs (≥ once/wk), hormone replacement therapy (among females), first-degree relative history of colorectal cancer (yes/no), and total energy intake; p-for-interaction was 0.026.